Abstract
Biologic agents are commonly used in treatment of rheumatoid diseases today. While being very potent in preventing the progression of diseases both clinical and radiological, they have far too many adverse effects as well. Infections, malignity, congestive cardiac failure, injection site reactions, vasculitis, neurological complications and dermatological complications can be mentioned among these adverse effects. In this composition, adverse effects and drug interactions of these biologic agents have been presented in details and with up-to date articles.
Keywords: Biologic agents, adverse effect, drug interactions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Adverse Effects and Drug Interactions of Biologic Agents
Volume: 9 Issue: 1
Author(s): Yasemin Turan
Affiliation:
Keywords: Biologic agents, adverse effect, drug interactions
Abstract: Biologic agents are commonly used in treatment of rheumatoid diseases today. While being very potent in preventing the progression of diseases both clinical and radiological, they have far too many adverse effects as well. Infections, malignity, congestive cardiac failure, injection site reactions, vasculitis, neurological complications and dermatological complications can be mentioned among these adverse effects. In this composition, adverse effects and drug interactions of these biologic agents have been presented in details and with up-to date articles.
Export Options
About this article
Cite this article as:
Turan Yasemin, Adverse Effects and Drug Interactions of Biologic Agents, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (1) . https://dx.doi.org/10.2174/187152310790711665
DOI https://dx.doi.org/10.2174/187152310790711665 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Treatment of Autoimmune Hepatitis
Current Clinical Pharmacology Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Resveratrol and Cardiovascular Disease
Current Nutrition & Food Science Comparative Analysis of the Rabbit Endothelial Progenitor Cells from Bone Marrow and Peripheral Blood Treated with Selenium Nanoparticles
Anti-Cancer Agents in Medicinal Chemistry Use of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke
Current Drug Targets - CNS & Neurological Disorders Hendra and Nipah Viruses: Pathogenesis and Therapeutics
Current Molecular Medicine Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
Current Drug Metabolism Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
Current Pharmaceutical Design Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Current Drug Targets Survey of the State of the Art in Biomaterials, Cells, Genes and Proteins Integrated into Micro- and Nanoscaffolds for Tissue Regeneration
Current Nanoscience Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology HSP60 as a Drug Target
Current Pharmaceutical Design Anti-atherosclerotic Effects of Spice-Derived Phytochemicals
Current Medicinal Chemistry Effect of the NMDA-Receptor Antagonist Dextromethorphan in Infant Rat Pneumococcal Meningitis
Current Drug Metabolism Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy
Current Pharmaceutical Design Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Current Pharmaceutical Design Olanzapine-Induced Reversible Pellagroid Skin Lesion
Current Drug Safety